Works matching DE "MEDULLOBLASTOMA"


Results: 1635
    1
    2

    Medulloblastoma: biology and immunotherapy.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1602930
    By:
    • Poggi, Alessandro;
    • Reggiani, Francesco;
    • Azevedo, Helena S.;
    • Raffaghello, Lizzia;
    • Pereira, Rui Cruz
    Publication type:
    Article
    3
    6
    7
    8
    11
    12
    13
    14
    15

    A genome-wide association study on medulloblastoma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 147, n. 2, p. 309, doi. 10.1007/s11060-020-03424-9
    By:
    • Dahlin, Anna M.;
    • Wibom, Carl;
    • Andersson, Ulrika;
    • Bybjerg-Grauholm, Jonas;
    • Deltour, Isabelle;
    • Hougaard, David M.;
    • Scheurer, Michael E.;
    • Lau, Ching C.;
    • McKean-Cowdin, Roberta;
    • Kennedy, Rebekah J.;
    • Hung, Long T.;
    • Yee, Janis;
    • Margol, Ashley S.;
    • Barrington-Trimis, Jessica;
    • Gauderman, W. James;
    • Feychting, Maria;
    • Schüz, Joachim;
    • Röösli, Martin;
    • Kjaerheim, Kristina;
    • The Cefalo Study Group
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Rethinking medulloblastoma from a targeted therapeutics perspective.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 3, p. 713, doi. 10.1007/s11060-018-2917-2
    By:
    • Hashimoto, Yuuri;
    • Penas-Prado, Marta;
    • Zhou, Shouhao;
    • Wei, Jun;
    • Khatua, Soumen;
    • Hodges, Tiffany R.;
    • Sanai, Nader;
    • Xiu, Joanne;
    • Gatalica, Zoran;
    • Kim, Lyndon;
    • Kesari, Santosh;
    • Rao, Ganesh;
    • Spetzler, David;
    • Heimberger, Amy
    Publication type:
    Article
    23
    24
    25

    Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 33, doi. 10.1007/s11060-018-2845-1
    By:
    • Bezerra Salomão, Karina;
    • Cruzeiro, Gustavo Alencastro Veiga;
    • Bonfim-Silva, Ricardo;
    • Geron, Lenisa;
    • Ramalho, Fernando;
    • Pinto Saggioro, Fabiano;
    • Serafini, Luciano Neder;
    • Antunes Moreno, Daniel;
    • de Paula Queiroz, Rosane Gomes;
    • dos Santos Aguiar, Simone;
    • Cardinalli, Izilda;
    • Yunes, José Andres;
    • Brandalise, Silvia Regina;
    • Brassesco, Maria Sol;
    • Scrideli, Carlos Alberto;
    • Gonzaga Tone, Luiz
    Publication type:
    Article
    26

    Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 2, p. 231, doi. 10.1007/s11060-018-2797-5
    By:
    • Łastowska, Maria;
    • Trubicka, Joanna;
    • Niemira, Magdalena;
    • Paczkowska-Abdulsalam, Magdalena;
    • Karkucińska-Więckowska, Agnieszka;
    • Kaleta, Magdalena;
    • Drogosiewicz, Monika;
    • Perek-Polnik, Marta;
    • Krętowski, Adam;
    • Cukrowska, Bożena;
    • Grajkowska, Wiesława;
    • Dembowska-Bagińska, Bożenna;
    • Matyja, Ewa
    Publication type:
    Article
    27
    28

    Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 205, doi. 10.1007/s11060-017-2713-4
    By:
    • de Rojas, Teresa;
    • Bautista, Francisco;
    • Flores, Miguel;
    • Igual, Lucía;
    • Rubio, Raquel;
    • Bardón, Eduardo;
    • Navarro, Lucía;
    • Murillo, Laura;
    • Hladun, Raquel;
    • Cañete, Adela;
    • Garcia-Ariza, Miguel;
    • Garrido, Carmen;
    • Fernández-Teijeiro, Ana;
    • Quiroga, Eduardo;
    • Calvo, Carlota;
    • Llort, Anna;
    • de Prada, Inmaculada;
    • Madero, Luis;
    • Cruz, Ofelia;
    • Moreno, Lucas
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 133, n. 1, p. 119, doi. 10.1007/s11060-017-2409-9
    By:
    • Fay-McClymont, Taryn;
    • Ploetz, Danielle;
    • Mabbott, Don;
    • Walsh, Karin;
    • Smith, Amy;
    • Chi, Susan;
    • Wells, Elizabeth;
    • Madden, Jennifer;
    • Margol, Ashley;
    • Finlay, Jonathan;
    • Kieran, Mark;
    • Strother, Douglas;
    • Dhall, Girish;
    • Packer, Roger;
    • Foreman, Nicholas;
    • Bouffet, E.;
    • Lafay-Cousin, Lucie
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45

    RalA is overactivated in medulloblastoma.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 130, n. 1, p. 99, doi. 10.1007/s11060-016-2236-4
    By:
    • Ginn, Kevin;
    • Fangman, Ben;
    • Terai, Kaoru;
    • Wise, Amanda;
    • Ziazadeh, Daniel;
    • Shah, Kushal;
    • Gartrell, Robyn;
    • Ricke, Brandon;
    • Kimura, Kyle;
    • Mathur, Sharad;
    • Borrego-Diaz, Emma;
    • Farassati, Faris
    Publication type:
    Article
    46
    47
    48
    49
    50